Parental Age and Schizophrenia Susceptibility
父母年龄和精神分裂症易感性
基本信息
- 批准号:8511320
- 负责人:
- 金额:$ 30.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-10 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAchondroplasiaAffectAgeApert syndromeAutistic DisorderBirthBlood specimenChildCodeDNADNA SequenceDataDelayed ChildbearingDiseaseDisease susceptibilityElderlyEventFathersGene Expression ProfileGene MutationGenetic TranscriptionGenetic VariationHumanIncidenceIndividualLinkMolecularMolecular BiologyMonozygotic TwinningMonozygotic twinsMorphologic artifactsMutationNeurodevelopmental DisorderParental AgesPaternal AgePatientsPersonality TraitsPlayPredispositionPsychosocial FactorRNARNA EditingRNA SequencesReportingRiskRisk FactorsRoleSample SizeSamplingSchizophreniaSiblingsTestingTimeVariantWhole Bloodage effectautism spectrum disorderbaseexomeexome sequencinghigh riskinsightinstrumentoffspringparalogous geneprobandpublic health relevancesperm cell
项目摘要
DESCRIPTION (provided by applicant): Paternal age at time of birth is a robust risk factor for schizophrenia and related neurodevelopmental disorders such as autism spectrum disorder. However, very little is known how advanced age of the father at time of birth may specifically result in increased risk to develop these diseases in the offspring. Several studies have shown that the increased de novo mutation rate in sperm of fathers with advancing age does insufficiently explain the increased risk observed in a number of monogenic diseases. A recent finding that there are widespread RNA and DNA sequence differences in the human transcriptome with individual variation in abundance of these differences has highlighted another possible mechanism playing a role in the molecular basis of disease susceptibility. In this explorative study we hypothesize that increased paternal age leads to increased abundance of RNA-DNA differences in the offspring, which contributes to disease susceptibility of schizophrenia. In hundred sibling pairs consisting of schizophrenia patient and unaffected sibling we will compare RNA and DNA sequence differences using whole blood samples. These subjects are selected for having younger (ages ¿25) and older (ages ¿40) fathers at time of birth, so that we can establish the effects of paternal age as well as disease status on the abundance of RNA and DNA sequence differences.
描述(由申请人提供):父亲出生时的年龄是精神分裂症和相关神经发育障碍(如自闭症谱系障碍)的一个强有力的风险因素。然而,很少有人知道父亲在出生时的高龄可能会特别导致后代患这些疾病的风险增加。几项研究表明,随着年龄的增长,父亲精子中的从头突变率增加,并不足以解释在一些单基因疾病中观察到的风险增加。最近的一项研究发现,在人类转录组中存在广泛的RNA和DNA序列差异,这些差异的个体差异丰富,这突出了另一种可能的机制,在疾病易感性的分子基础中发挥作用。在这项探索性研究中,我们假设父亲年龄的增加导致后代中RNA-DNA差异的增加,这有助于精神分裂症的疾病易感性。在由精神分裂症患者和未受影响的同胞组成的100对同胞中,我们将使用全血样本比较RNA和DNA序列差异。这些受试者在出生时有年轻(25岁)和年长(40岁)的父亲,因此我们可以确定父亲年龄以及疾病状态对RNA和DNA序列差异丰度的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roel A Ophoff其他文献
Roel A Ophoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roel A Ophoff', 18)}}的其他基金
Improving Prediction of Prognosis in Frontotemporal Dementia Using Epigenetic and Genetic Markers of Biological Aging and Disease
利用生物衰老和疾病的表观遗传和遗传标记改善额颞叶痴呆的预后预测
- 批准号:
10196850 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Joint genomic and statistical analyses of schizophrenia and bipolar to decipher genetic susceptibility
精神分裂症和躁郁症的联合基因组和统计分析以破译遗传易感性
- 批准号:
10349574 - 财政年份:2018
- 资助金额:
$ 30.8万 - 项目类别:
Integrating case-control transcriptomic and genetic data in admixed individuals to identify disease genes for schizophrenia and bipolar disorder
整合混合个体的病例对照转录组和遗传数据,以确定精神分裂症和双相情感障碍的疾病基因
- 批准号:
10681798 - 财政年份:2018
- 资助金额:
$ 30.8万 - 项目类别:
Exposure to cyanobacteria and BMAA in ALS through the gut environment microbiome
ALS 患者通过肠道环境微生物组接触蓝藻和 BMAA
- 批准号:
8758601 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
Exposure to cyanobacteria and BMAA in ALS through the gut environment microbiome
ALS 患者通过肠道环境微生物组接触蓝藻和 BMAA
- 批准号:
8934118 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
Rare Coding Variants at Microdeletion Regions and Schizophrenia Susceptibility
微缺失区域的罕见编码变异与精神分裂症易感性
- 批准号:
8032372 - 财政年份:2011
- 资助金额:
$ 30.8万 - 项目类别:
Rare Coding Variants at Microdeletion Regions and Schizophrenia Susceptibility
微缺失区域的罕见编码变异与精神分裂症易感性
- 批准号:
8328608 - 财政年份:2011
- 资助金额:
$ 30.8万 - 项目类别:
Genomic Studies of Bipolar Disorder in a Large Cohort from The Netherlands
荷兰大群体双相情感障碍的基因组研究
- 批准号:
8470241 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别:
Genomic Studies of Bipolar Disorder in a Large Cohort from The Netherlands
荷兰大群体双相情感障碍的基因组研究
- 批准号:
8114989 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别:
相似海外基金
Exploring the genetic background of normal facial variation to dissect disease expressivity, using achondroplasia as a model.
以软骨发育不全为模型,探索正常面部变异的遗传背景,以剖析疾病的表现力。
- 批准号:
486257 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Studentship Programs
Development of therapeutic drugs fro achondroplasia-Examination of FGFR3 inhibitory effects of meclizine hydrochloride
软骨发育不全治疗药物的研制——盐酸美其嗪对FGFR3抑制作用的考察
- 批准号:
21H03063 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of the relationship between obesity and type 2 diabetes in achondroplasia
阐明肥胖与软骨发育不全中 2 型糖尿病之间的关系
- 批准号:
19K23996 - 财政年份:2019
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Examination of obesity and insulin resistance for patient cohort and disease-specific iPS cells with achondroplasia
检查患有软骨发育不全的患者群体和疾病特异性 iPS 细胞的肥胖和胰岛素抵抗
- 批准号:
18K07877 - 财政年份:2018
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Early intervention for children with achondroplasia: self-management and self-efficacy
软骨发育不全儿童的早期干预:自我管理和自我效能
- 批准号:
26861923 - 财政年份:2014
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8675729 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8129527 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8277448 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
8476987 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别:
Delivery of Soluble FGFR3 as a Treatment for Achondroplasia
递送可溶性 FGFR3 作为软骨发育不全的治疗方法
- 批准号:
7987228 - 财政年份:2010
- 资助金额:
$ 30.8万 - 项目类别: